soul trial oral semaglutide cardiovascular outcomes results 2024 Projected reduction in major adverse events among high-risk U.S. adults with type 2 diabetes eligible for semaglutide: a trial–based analysis using NHANES (1988–2018) cycles SOUL: Oral Semaglutide Cuts CV

This underscores the need for integrated strategies combining pharmacotherapy with personalised dietary interventions and resistance exercise [24, 71], not only to preserve MM and support metabolic health but also to minimise the risk of nutritional deficiencies and sarcopenia [79,80,81]

Su QJ, Ashenhurst JR, Xu W, et al

Amongst the different factors that protect the cell against OS, the members of the glutathione S-transferase (GST) superfamily play an important role

These personal experiences show why many women wonder if GLP-1 medications might support their health beyond managing weight

Je bent verantwoordelijk voor het tijdig, juist en volledig voeren van de financile administratie